psoriasis vulgaris
Conditions
Interventions
Intervention group:Auricular therapy combined with topical Western m
control group:topical Western medicine
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 70 years old, male or female patients; 2. PASI more than 7 and less than 20, and BSA less than 30 %; 3. Inform consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have a arthropathic, pustule or erythrodermic psoriasis as well as inverse psoriasis or exclusively involves the face; 2. Women who are pregnant, breastfeeding, or who are planning to get pregnant within 1 year; 3. SAS more than 50 or SDS more than 53, or with other psychiatric disorders; 4. With history of cardiovascular, respiratory, digestive, urinary, and hematologic disease, which cannot controlled through common treatment. Either with cancer, infection, electrolyte imbalance, acid-base disturbance and calcium metabolic disorder; 5. Allergic to any medicine or ingredients used in this study; 6. Participating other clinical trials or participated within 1 month; 7. Topical treatments (i.e. corticosteroids, Retinoic acid) within 2 weeks; systemic therapy or phototherapy (UVB and PUVA) within 4 weeks; biological therapy within 12 weeks; 8. Patients need systemic treatment prescribed by doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse rate in treatment period/follow-up period;Psoriasis Area and Severity Inde; | — |
Secondary
| Measure | Time frame |
|---|---|
| Relapse time interval;Onset time;Cumulative consumption of topical western medicine;Pruritus Scores on the Visual Analogue Scale;Dermatology Life Quality Index;TNF;IL-8;IL-17;IL-12;IL-23;IL-10; | — |
Countries
China
Contacts
Public ContactChuanjian Lu
Outcome results
None listed